Regulation of T- and B-cell interactions determines the clinical phenotype associated with donor-specific antibodies
Kidney International, ISSN: 0085-2538, Vol: 101, Issue: 5, Page: 877-879
2022
- 2Citations
- 1Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations2
- Citation Indexes2
- Captures1
- Readers1
Article Description
The cellular mechanisms that regulate donor-specific antibody formation and antibody-mediated rejection remain unknown. In this issue, Louis et al. report that specific T-regulatory cell and B-regulatory transitional cell subsets are concomitantly diminished in patients with donor-specific antibody and consequent antibody-mediated rejection and advance alterations in specific cytokines and costimulatory molecules as important mechanisms by which these cells may suppress donor-specific antibody formation and, independently, progression to antibody-mediated rejection.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0085253822001806; http://dx.doi.org/10.1016/j.kint.2022.02.020; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85128127529&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/35461614; https://linkinghub.elsevier.com/retrieve/pii/S0085253822001806; https://dx.doi.org/10.1016/j.kint.2022.02.020
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know